Medical Weight Loss for Indianapolis, Indiana Residents

Indianapolis, Indiana residents get physician-supervised weight loss by telehealth from New Hope Weight Loss: a $119 doctor review, then compounded semaglutide from $166/month or tirzepatide from $233/month.

Physician-supervised GLP-1 programs from $166/month, serving Indianapolis through telehealth from our Costa Mesa, California clinic. Doctor review $119. Over 5,400 patients treated.

Serving Indianapolis, Indiana by telehealth: your consultation, prescription, and follow-ups all happen by secure video, with compounded medication shipped to your door. Our only physical clinic is in Costa Mesa, California; everything else is virtual. Doctor review just $119 (medication separate).

Why Indianapolis Residents Choose New Hope Weight Loss

You never have to leave Indianapolis to work with us. The entire program runs by telehealth from our clinic in Costa Mesa, California, so your consultation, your follow-ups, and your dose adjustments all happen by video and message from wherever you are in Indiana. Whether you live near Downtown, Broad Ripple, Fountain Square, Mass Ave, and the greater Indianapolis area or further out, the care is identical. No commute, no waiting room, no rearranging your week around an appointment across town.

Indianapolis is served through telehealth from our Costa Mesa, California clinic. The consultation, prescription, and follow-up all happen by secure video.

Whether you are near downtown Indianapolis or somewhere quieter in Indiana, the same doctor-supervised plan runs over telehealth, with our only physical location remaining in Costa Mesa, California. We care for patients throughout Downtown, Broad Ripple, Fountain Square, Mass Ave, and the greater Indianapolis area. Your plan is shaped around your own history, the medications you have tried, and the goals you bring, not a one-size template applied to every Indianapolis patient.

Tirzepatide from $233 per month and semaglutide from $166 per month cost the same whether you are in downtown Indianapolis or a rural corner of Indiana. If you and Dr. Sharma decide tirzepatide fits your goals, Indianapolis patients can begin from $233 per month, billed apart from your initial $119 visit. New Hope Weight Loss treats patients throughout Indiana entirely by telehealth from our Costa Mesa, California clinic, so the same physician care comes to you wherever you live in the state.

GLP-1 Weight Loss Programs Available

Start with the 90-Day Metabolic Reset

Semaglutide anchors our most-requested program, and it shares an active ingredient with Wegovy and Ozempic. You can begin from $166 a month, or cover all 90 days for $499. In trials of the branded medication, average body-weight loss landed around 15 to 17 percent, though results vary and compounded semaglutide is neither FDA-approved nor brand-identical. Patients across Indianapolis meet with Dr. Sharma entirely by telehealth.

Step up to tirzepatide when it fits

Priced from $233 a month, tirzepatide pairs GLP-1 with GIP for a dual effect. Branded-drug trials recorded up to 22.5 percent loss at qualifying doses, a ceiling figure, not an average. Same active ingredient as Mounjaro and Zepbound.

Everything opens with a $119 physician review. Medication billed separately. We take HSA, FSA, Klarna, and Affirm.

How Telehealth Works for Indianapolis

Think of it as four easy moments. You begin with an online intake quiz that asks about your weight, your health history, and what you want to achieve. Dr. Anjmun Sharma then reviews your answers and meets you by secure video, generally within 48 hours, to talk honestly about whether compounded semaglutide or tirzepatide could help you. If she prescribes one, a state-licensed 503(a) pharmacy fills it and ships it to your Indianapolis address in protective cold-pack packaging. Finally, your follow-up care is delivered by video, so people throughout can stay on plan without ever sitting in a waiting room.

Frequently Asked Questions, Indianapolis

Does New Hope Weight Loss have a presence in Indianapolis?

Our presence in Indianapolis is through telehealth rather than a storefront. The clinic itself is in Costa Mesa, California, our sole physical location. We serve Indianapolis, Indiana patients online, and Dr. Anjmun Sharma confirms your eligibility for compounded semaglutide or tirzepatide during a private video consultation.

Could a Indianapolis patient complete care without leaving home?

Yes, staying home is the norm. Everything for Indianapolis patients runs over telehealth, including the initial consult, dose adjustments, and check-ins. After approval, your medication travels to Indianapolis in insulated cold-pack shipping that protects it from temperature swings during delivery.

How are Indianapolis patients charged?

There is a $119 fee for the physician review. Semaglutide starts at $166 monthly, with a 90-day option at $499, and tirzepatide at $233 monthly. The medication itself is a separate cost. We accept HSA, FSA, Klarna, and Affirm, and we add no distance surcharge for Indianapolis.

What areas of Indianapolis do you serve?

We serve patients from across Indianapolis by telehealth, including Downtown, Broad Ripple, Fountain Square, Mass Ave, and the greater Indianapolis area.

Can Indianapolis patients do the whole program by video?

Yes. Indianapolis patients complete the intake form, the video consultation with Dr. Sharma, dose check-ins, and follow-up entirely by telehealth, with compounded medication shipped to their address.

Indianapolis Residents, Get Started Today

Doctor review $119. Semaglutide from $166/mo. Tirzepatide from $233/mo. Medication separate.

Start My Journey →

New Hope Weight Loss | clinic at 1503 South Coast Drive, Suite 322, Costa Mesa, CA 92626 | (657) 837-3342 | Serving Indianapolis, Indiana by telehealth. Telehealth availability and eligibility are confirmed during the medical consultation.

Wegovy® and Ozempic® are registered trademarks of Novo Nordisk A/S. Mounjaro® and Zepbound® are registered trademarks of Eli Lilly and Company. New Hope Weight Loss is not affiliated with or endorsed by these companies. Compounded semaglutide and tirzepatide are prepared by licensed U.S. pharmacies and are not FDA-approved, not brand-identical, and not reviewed by the FDA for safety, effectiveness, or quality.